Adjudera

Awarded

LOT 6: Innovative technologies for manufacturing and quality control of medicines

Track this recordFree account — get alerted when a contract here runs out.
Buyer
European Medicines Agency, MED - European Medicines Agency
Winners
NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO
Contract value
no value published
Bids received
4
Published
9 Jul 2026
Awarded
17 Mar 2026
Contract start
17 Mar 2026
Contract end
14 Feb 2028estimated
Sector
Research and development
Region
Groot-Amsterdam
Source
Original notice on TED (478941-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
Data Management- Anonymization and redaction of documents and datasetsEuropean Medicines Agency, MED - European Medicines AgencyIQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.—4 Sept 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseasesEuropean Medicines Agency, MED - European Medicines AgencyIstituto di Ricerche Farmacologiche Mario Negri, KREATIS—1 Sept 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicinesEuropean Medicines Agency, MED - European Medicines AgencyNATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO—1 Sept 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 more—1 Sept 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 more—1 Sept 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 more—1 Sept 2026